Full-Time

Senior Clinical Engineer

Updated on 8/21/2026

Imperative Care

Imperative Care

201-500 employees

Stroke-care medical devices and trials

Compensation Overview

$140k - $150k/yr

+ Stock options + 401(k) plan

Campbell, CA, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Inventory Management

Get referred to Imperative Care

See people who can refer or advise you

Requirements
  • A Bachelor of Science degree in Engineering or a related discipline, or an equivalent combination of education and experience.
  • At least 2 years of experience with increasing responsibility in novel product or procedure development in the medical device industry, or equivalent experience.
  • Experience in vascular or neurovascular interventions or surgical robotics.
  • The ability to take initiative to start projects and create and meet deadlines.
  • Demonstrated success working with cross-functional teams and customers, including physicians and hospital staff.
  • Previous involvement in at least one full product development cycle.
  • Knowledge of and exposure to product testing and data collection.
  • Experience working under quality systems designed to meet governmental regulations, such as FDA Quality System Regulation, ISO 13485, and the Medical Devices Directive.
  • Strong working knowledge of relevant regulatory standards applicable to the specific product or project.
  • Familiarity with design control procedures and requirements.
  • The ability to work independently or in a team setting.
  • The ability to travel as required for the role.
Responsibilities
  • Gather clinical or user data to inform the definition, specification, design, and testing of pre-commercial and commercial vascular and stroke products.
  • Interact directly with clinical customers and cross-functional internal teams.
  • Lead support for preclinical testing, training, and support in clinical procedures for internal and external stakeholders using the products.
  • Serve as a clinical engineering team member for product development, including preclinical testing, bench testing, model development, in-vitro test methods and plans, and in-vivo animal studies.
  • Provide team members and management with updates regarding project status and critical issues that may affect project completion dates.
  • Create and execute design verification and testing plans, and participate in team meetings where progress is discussed and decisions are made.
  • Ensure work supports preclinical testing of new products within design controls and applicable quality standards, and ensure products are designed, developed, tested, manufactured, and documented according to applicable global regulatory requirements.
  • Support new team members or interns through product and procedure training as needed.
  • Ensure detailed plans are fully executed for internal development projects involving preclinical testing, bench testing, model development, in-vitro test methods and plans, and in-vivo animal studies.
  • Interact directly with clinical customers to identify system customer-input requirements.
  • Plan and conduct ethnography studies.
  • Interact directly with commercial and marketing partners to identify gaps and potential solutions to existing customer needs.
  • Provide input to help quantify product performance requirements.
  • Work with design engineers to translate customer-input requirements into design-input requirements.
  • Drive completion of preclinical testing, including validation testing.
  • Develop test models.
  • Create test plans, protocols, and reports for all testing, ensuring documentation aligns with company procedures and the quality management system.
  • Plan, conduct, and complete laboratory activities, including maintaining inventory, ordering materials, setting up laboratory areas, and keeping them clean.
  • Handle complaints and market claims as requested.
  • Support commercial events such as conferences by providing product demonstrations or physician engagements.

Imperative Care develops medical technologies for stroke and vascular diseases, delivering devices and solutions to healthcare providers to improve patient care. Its approach centers on rapid development and testing, guided by clinical evidence and feedback from physicians, including large multicenter trials like the Imperative Trial. The company moves from concept to market by conducting clinical research and refining products through physician input, with revenue generated from selling devices to hospitals and clinicians. Its differentiator is the combination of evidence-based development, physician-driven insights, and an agile response to the evolving needs of stroke care. The overarching goal is to improve outcomes for stroke patients by providing practical, clinically validated tools that healthcare teams can adopt quickly and effectively.

Company Size

201-500

Company Stage

N/A

Total Funding

$598M

Headquarters

Campbell, California

Founded

2015

Get referred to Imperative Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • $100 million March 2026 financing funds commercialization, Telos development, and evidence generation.
  • June 2026 SYMPHONY-PE analysis strengthened Symphony after FDA clearance in September 2025.
  • Jay Martin joined as CCO in May 2026, sharpening sales execution and partnerships.

What critics are saying

  • Imperative Care faces Inari Medical patent disputes; PTAB instituted reviews in January 2026.
  • Penumbra's Thunderbolt and Boston Scientific scale intensify competition in neurothrombectomy.
  • Commercialization depends on procedure adoption; weak uptake would strand Telos and burn cash.

What makes Imperative Care unique

  • Imperative Care spans stroke and pulmonary embolism with Zoom, Symphony, and Prodigy systems.
  • The July 2026 Ikon 24 Pro guidewire deepens its integrated, procedure-specific platform.
  • Telos robotic thrombectomy targets remote and on-site intervention, unlike single-device rivals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

Mental Health Support

Paid Vacation

Paid Sick Leave

Paid Holidays

Parental Leave

Company Equity

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-2%
Associated Press
Jul 16th, 2026
Imperative Care launches Ikon 24 Pro guidewire to enhance stroke procedure efficiency

Imperative Care has launched the Ikon 24 Pro Guidewire, a neurovascular guidewire designed to improve vascular access during stroke procedures. The device features a uniform 0.024-inch diameter throughout its length, a progressive support profile matched to Zoom Catheters, and enhanced tactile feedback for precise control. The guidewire is engineered to work with Imperative Care's Zoom Stroke System, which includes various catheters designed for clot removal in acute ischemic stroke patients. The system's asymmetric tip design provides 15% greater clot engagement area compared to traditional flat-tip catheters. Dr Kunal Vakharia from the University of South Florida, amongst the first physicians to use the device, noted its reliable balance of support and flexibility, stating it made stroke procedures more efficient. Imperative Care, based in Campbell, California, focuses on advancing treatments for thromboembolic disease.

Cardiac Vascular News
Jul 16th, 2026
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures

Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures More in Neuro: CAMPBELL, Calif.-(BUSINESS WIRE)-Imperative Care launches Ikon 24 Pro Guidewire, enhancing the Zoom Stroke System to support more efficient stroke procedures. See full post here as originally published on this site

Business Wire
May 14th, 2026
Imperative Care appoints Jay Martin as chief commercial officer

Imperative Care, a medical technology company focused on thromboembolic disease treatments, has appointed Jay Martin as Chief Commercial Officer. Martin will lead commercial strategy, expand strategic partnerships and build infrastructure to support the company's growth and commercialisation efforts. Martin brings over 25 years of executive leadership experience in medical devices, robotics and imaging. Most recently, he served as President of VulcanForms, where he helped build a backlog exceeding $1 billion in 18 months. He previously spent eight years at Globus Medical, serving as President of Imaging, Navigation and Robotics, and was part of the leadership team that grew the company from approximately $400 million to over $2 billion in revenue. The Campbell, California-based company develops treatments for patients suffering from blood clot formation in veins and arteries.

Business Wire
Mar 17th, 2026
Imperative Care raises $100M to advance stroke treatment tech and robotic platform

Imperative Care, a medical technology company treating thromboembolic disease, has closed an oversubscribed $100 million convertible note financing. The round was co-led by new investors Elevage Medical Technologies and Perceptive Advisors, alongside existing investor Catalio Capital Management. New investors Longaeva Partners and Brown Advisory participated, with support from existing backers including Ally Bridge Group and Bain Capital Life Sciences. Evan Melrose, CEO of Elevage Medical Technologies, has joined Imperative Care's board of directors. The funding will support commercialisation of the company's stroke and vascular thrombectomy portfolios, next-generation product development including the Telos robotic platform, and clinical evidence generation. Imperative Care's products have been used in over 78,000 procedures commercially. BofA Securities and J.P. Morgan served as joint placement agents.

Medical Device Network
Jan 29th, 2026
Imperative Care introduces ischaemic stroke treatment catheter

Imperative Care introduces ischaemic stroke treatment catheter. The Zoom 4S catheter is designed to simplify stroke thrombectomy by reducing device exchanges. Imperative Care has launched the Zoom 4S catheter, an advanced thrombectomy device for treating ischaemic stroke. Marking the latest addition to its Zoom Stroke System, the new catheter aims to expand access to the ADAPT 2.0 technique. It aims to address a broader range of patient anatomies during aspiration thrombectomy procedures. It is designed to simplify stroke thrombectomy by reducing device exchanges and introducing a single setup approach. The ADAPT 2.0 technique, central to this advancement, involves positioning an intracranial 0.088in catheter closer to the clot and utilising an asymmetric tip design for targeted aspiration. The system applies Continuous Dual AspiraTion (CDAT) through two catheters for enhanced clot ingestion. First published in 2014, the original ADAPT technique showed the clinical benefits of direct aspiration as a frontline treatment for acute ischaemic stroke. US tariffs are shifting - will you react or anticipate? Don't let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Expanding on this groundwork, Imperative Care has advanced the method with ADAPT 2.0, emphasising rapid thrombectomy procedures that do not require several device exchanges. Imperative Care chief technology officer Richard Leparmentier said: "At Imperative Care, Medicaldevice Network believe that it is its responsibility to bring the most advanced technologies to market, with the goal of improving patient outcomes by shaping the arc of innovation in stroke care. "With a focus on reducing treatment times and streamlining stroke procedures, Medicaldevice Network has purposefully engineered one simple Zoom setup to bring the key procedural benefits of the ADAPT 2.0 technique to more patients. "With the introduction of Zoom 4S, Imperative Care is heralding this new chapter of stroke care, as we believe this combination of technologies will provide physicians with the confidence to effectively address a broad range of clot locations using a single setup." The complete Zoom Stroke System includes catheters such as Zoom 35, 4S, 45, 55, 71 and 7X; as well as the Zoom 88 Large Distal Platform and Zoom 88 Support. In September 2025, Imperative Care received 510(k) clearance from the US Food and Drug Administration (FDA) for its Symphony thrombectomy system, which is designed to treat pulmonary embolism (PE).